-transparent.png){kind=logo}
Fetal tachyarrhythmia may constitute a risk for the fetus, therefore early treatment is indicate for all cases of tachydysrhythmia, with or without hydrops, in order to prevent irreversible hydrops. A case report is described of supraventricular paroxysmal tachycardia with digoxin in utero therapy in which pharmacological intervention was successful. Some comments are regarding the experience of the multidisciplinary team at Bissaya-Barreto Maternity in the treatment and orientation of fetal tachydysrhythmias.
Related Publications
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
November 1974,
The American journal of cardiology,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
April 1989,
Kardiologiia,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
March 1983,
Klinicheskaia meditsina,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
November 1984,
Obstetrics and gynecology,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
January 1980,
Sovetskaia meditsina,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
May 1976,
Rational drug therapy,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
February 1994,
American heart journal,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
February 1975,
Lancet (London, England),
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
March 1949,
American heart journal,
I S Silva, and
C Nunes, and
G Mimoso, and
E Castela, and
J Mesquita
April 1964,
American heart journal,
